| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |